Venous thromboembolism, atrial fibrillation requiring coumarin therapy, target inr in the low intensity range
Item
patients with either venous thromboembolism (vte) or atrial fibrillation (af) requiring coumarin therapy for at least 12 weeks and a target inr in the low intensity range (inr range 2-3 in the united kingdom, sweden, germany, austria and greece and inr 2.5-3.5 in the netherlands)
boolean
C1861172 (UMLS CUI [1,1])
C0686904 (UMLS CUI [1,2])
C0010206 (UMLS CUI [1,3])
C0004238 (UMLS CUI [2,1])
C0686904 (UMLS CUI [2,2])
C0010206 (UMLS CUI [2,3])
C1521840 (UMLS CUI [3,1])
C0525032 (UMLS CUI [3,2])
Age
Item
age ≥ 18 years
boolean
C0001779 (UMLS CUI [1])
Ability to attend scheduled visits
Item
ability to attend scheduled visits
boolean
C2827364 (UMLS CUI [1,1])
C0085732 (UMLS CUI [1,2])
Informed consent
Item
signed informed consent
boolean
C0021430 (UMLS CUI [1])
Presence of a mechanical heart valve
Item
presence of a mechanical heart valve
boolean
C0493527 (UMLS CUI [1])
Severe cognitive impairment
Item
severe cognitive impairment
boolean
C3554639 (UMLS CUI [1])
Known genotype cyp2c9 or vkorc1
Item
known genotype cyp2c9 or vkorc1 at start of the study
boolean
C1332829 (UMLS CUI [1])
C1428184 (UMLS CUI [2])
Previous or current treatment with any coumarin
Item
previous or current treatment with any coumarin
boolean
C0010206 (UMLS CUI [1,1])
C2827774 (UMLS CUI [1,2])
C0010206 (UMLS CUI [2,1])
C1514463 (UMLS CUI [2,2])
Pregnancy or lactation
Item
pregnancy or lactation
boolean
C0032961 (UMLS CUI [1])
C0022925 (UMLS CUI [2])
Ineligibility
Item
non-eligible subject
boolean
C1512714 (UMLS CUI [1])